Myeloablative I-131-Tositumomab With Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years With B Cell Lymphoma
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.02.004
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Elsevier BV